David N. Lefcowitz

Involved in representing complainant HTC in an investigation involving certain user interface features in Apple’s iPhones, iPads, and iPod Touches.

Represented VIA Technologies and Centaur in ITC investigation against Apple asserting infringement of microprocessor architectures and the instruction sets associated with microprocessors. Served in a leading role on the team representing Via and Centaur, taking and defending witness testimony at deposition. The case settled favorably prior to an initial determination.

Represented Astellas in an action to prevent generic competition in pharmacological heart stress agent Adenoscan®. Tried and settled favorably to patent holder after trial.

Represented Eli Lilly in Hatch-Waxman patent infringement litigations against several ANDA filers seeking FDA approval to market generic versions of Eli Lilly's Cymbalta®. The S.D. Indiana entered judgment before trial in favor of Eli Lilly and against all the ANDA filers on all issues, resulting in orders and judgment maintaining Cymbalta's® market exclusivity through the end of its patent life.

Represented complainant Hillcrest Laboratories against Nintendo's Wii video game system for infringement of Hillcrest's fundamental patents on 3D pointing technology; settled favorably after full evidentiary hearing but before ALJ's initial determination.

Represented SAP in a patent litigation and subsequent appeal involving software products; Obtained a stipulated judgment of non-infringement in light of the court's Markman ruling.